Skip to main content

Table 1 Summary of clinical findings for epilepsy patients and controls

From: Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions

Pathology type Number of cases Gender (males/females) Mean age at surgery (years/range) Localization Mean duration of epilepsy (years/range)
FCD I 6 3/3 27.8 (19 to 39) 4 Temporal 7.7 (6 to 13)
2 Frontal
FCD IIa 6 3/3 24.3 (11 to 24) 3 Frontal 6.1 (2 to 11)
3 Temporal
FCD IIb 15 7/8 23.2 (17 to 41) 8 Temporal 7.8 (3 to 15)
7 Frontal
Cortical tubers (TSC) 6 3/3 17.8 (5 to 35) 3 Frontal 13.5 (2.8 to 34)
3 Temporal
2 Parietal
GG 15 8/7 29.2 (15 to 46) Temporal 7.8 (3 to 15)
Controls (no epilepsy) 6 3/3 30.1 (20 to 41) Temporal -
  1. FCD, focal cortical dysplasia; TSC, tuberous sclerosis complex; GG, ganglioglioma.